Diagnos Laboratorium Utama Tbk. vs Tigaraksa Satria Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 24.4K 24h volume), while Tigaraksa Satria Tbk. trades at Rp4,830 (market cap 4.34T, 400 24h volume). The key difference: Tigaraksa Satria Tbk. is far larger — about 14.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (24.4K versus 400). Which is the better fit depends on your goals.
| DGNS | TGKA | |
|---|---|---|
Market Cap | 308B | 4.34T |
Volume | 24.4K | 400 |
Lot | 244 | 4 |
Turnover | 5.54M | 1.92M |
Average Price | 227.25 | 4,787.5 |
Value | 5.54M | 1.92M |
Indicative Equilibrium Price | 230 | — |
Indicative Equilibrium Volume | 110 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Tigaraksa Satria Tbk (the Company) was established in Jakarta based on notarial deed No. 35 of M.M.I. Wiardi, S.H., dated November 17, 1986. PT. Tigaraksa Satria is a distributor of Nutrition, Chemicals, Cosmetic, Books, Garments and other consumer goods. Founded in 1987 as a subsidiary of PT. Tigaraksa, the company handles the dosmetic distribution products for more than 20 pricipals.
Read more on TGKA →